Pharmafile Logo
Pharmafocus logo
Advanced Search

Julie Beeso joins Envision Pharma Group as new Global Director

January 18, 2022
Manufacturing and Production

Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement. Julie has worked for almost …

Appointment
mario_torchia_ist

Mario Torchia appointed as new Vice President of Sales & Marketing at InSilicoTrials

January 18, 2022
Manufacturing and Production

InSilicoTrials, a leader in simulation software solutions for healthcare, has announced Mario Torchia’s appointment. Torchia recently led the Sales Strategy …

Appointment

Enhertu granted priority review in US for patients with HER2-positive metastatic breast cancer

January 18, 2022
Manufacturing and Production

Enhertu, manufactured by AstraZeneca and Daiichi Sankyo, has been accepted for the treatment of adult patients in the US with …

News

SMC accept Enhertu for the treatment of HER2 positive metastatic breast cancer

January 18, 2022
Manufacturing and Production

Daiichi Sankyo and AstraZeneca have announced that the SMC has accepted Enhertu® for use within NHS Scotland for the treatment …

News
andrei_r_-_shutterstock_1935537274_720

Almirall and IRB Barcelona research for skin disease therapeutics discovery

January 18, 2022
Manufacturing and Production

Almirall and IRB Barcelona (the Institute for Research in Biomedicine) have announced a research collaboration to identify the new oral …

News

Abbisko Therapeutics collaborates with Lilly to discover novel molecules

January 18, 2022
Manufacturing and Production

Abbisko Therapeutics announced that it has entered into a partnership and exclusive licensing agreement with Eli Lilly and Company. This …

News

Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases

January 17, 2022
Sales and Marketing

Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …

News

NICE draft guidance recommends new treatment for rare liver condition

January 17, 2022
Sales and Marketing

On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …

News

FDA places Alzheimer’s therapeutic IND Application on hold

January 17, 2022
Sales and Marketing

The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …

News

COVID-19 self-isolation cut to five full days in England

January 17, 2022
Sales and Marketing

The minimum self-isolation period for people testing positive for COVID-19 in England has been cut from seven days to five …

News

AstraZeneca and Scorpion strike $1.5bn deal against hard-to-treat proteins

January 14, 2022
Medical Communications

AstraZeneca and Scorpion have partnered to develop precision medicines against previously hard-to-target cancer proteins. The collaboration, valued at more than …

News

South Africa study shows J&J booster 85% effective against Omicron hospitalisation

January 14, 2022
Medical Communications

The head of South Africa’s Medical Research Council (SAMRC) has revealed that a J&J booster shot is 85% effective in …

News

First melanoma test to offer reassurance of low risk of cancer spread

January 14, 2022
Medical Communications

A new test reliably predicting the spread or return of the most deadly form of skin cancer has been developed …

News

WHO recommend two new COVID-19 treatments

January 14, 2022
Medical Communications

WHO approved two new treatments for COVID-19 on 14 January, as Omicron cases continue globally, and WHO predicting half of …

News

Benevolent AI and AstraZeneca expand collaboration on heart failure and systemic lupus discovery

January 13, 2022
Business Services

Leading clinical stage AI drug discovery company, Benevolent AI, has expanded its AI-driven drug discovery collaboration with AstraZeneca. This means …

News

Abivax receive EMA scientific advice support for ulcerative colitis trial

January 13, 2022
Business Services

Abivax have received scientific advice from the EMA supporting advancing ABX464 into Phase III clinical testing, for the treatment of …

News

Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China

January 13, 2022
Business Services

Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …

News

PCN-101 R-ketamine Programme receives FDA Investigational New Drug clearance

January 13, 2022
Business Services

The FDA has given Investigational New Drug (IND) clearance to atai Life Sciences, to conduct a clinical DDI study of …

News

White House announces plans to double COVID-19 tests for schools

January 12, 2022
Research and Development

The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …

News

South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine

January 12, 2022
Research and Development

Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026